Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

NCT00662870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1941

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Whooping Cough
Polio
Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)
BIOLOGICAL: Pentacel: DTaP-IPV/Hib

Sponsor

Sanofi